AVB-114
Perianal Fistulas in Crohn's Disease
Phase 2Active
Key Facts
About Avobis Bio
Avobis Bio is a private, pre-revenue biotech founded in 2020 and headquartered in San Diego, CA, USA. The company is pioneering an implantable tissue healing technology platform that integrates mesenchymal stem cells (MSCs) with bioabsorbable materials to create durable, curative therapies for immune-mediated diseases and oncology. Its lead candidate, AVB-114, is in clinical development for Crohn's perianal fistulas, a condition with significant unmet need. The company leverages strategic partnerships with Mayo Clinic and W. L. Gore & Associates and is led by a seasoned team with deep experience in regenerative medicine and product development.
View full company profile